A major national 340B provider advocacy group is condemning the newly introduced 340B ACCESS Act, arguing that the proposed overhaul [...] …
Category: Providers
A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Medicare Part D beneficiaries who received retail and specialty drugs from prescribers at 340B disproportionate share hospitals (DSH) were more [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Teva Pharmaceuticals recently added the 40th drug to the list of medications included in its contract pharmacy policy restrictions for [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appeals court today decided that the 340B statute does not prohibit drugmakers from placing conditions on the distribution [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Shortly before adjourning, the Minnesota legislature cleared and sent to the governor legislation to bar 340B contract pharmacy access restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Hospitals in the 340B program should respond to increasing drugmaker contract pharmacy restrictions by opening their own pharmacies or selectively [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Virginia Gov. Glenn Youngkin (R) late Friday vetoed a bill that would have prohibited drugmaker contract pharmacy restrictions on grantee [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Maryland Gov. Wes Moore (D) this morning is signing legislation to make Maryland the sixth state to prohibit drugmaker 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program continued to expand in 2023, exceeding $124 billion in wholesale acquisition cost (WAC) sales—up from $107 billion [...] …